| The role of senescence in the development of nonalcoholic fatty liver disease and progression to nonalcoholic steatohepatitis AM Papatheodoridi, L Chrysavgis, M Koutsilieris, A Chatzigeorgiou Hepatology 71 (1), 363-374, 2020 | 160 | 2020 |
| Cellular senescence and hepatitis B‐related hepatocellular carcinoma: an intriguing link ND Karakousis, A Papatheodoridi, A Chatzigeorgiou, G Papatheodoridis Liver International 40 (12), 2917-2927, 2020 | 27 | 2020 |
| Taxanes during pregnancy in cervical cancer: A systematic review and pooled analysis F Zagouri, AM Korakiti, R Zakopoulou, A Kyriazoglou, E Zografos, ... Cancer Treatment Reviews 79, 101885, 2019 | 26 | 2019 |
| Hepatic senescence accompanies the development of NAFLD in non-aged mice independently of obesity II Moustakas, A Katsarou, AI Legaki, I Pyrina, K Ntostoglou, ... International journal of molecular sciences 22 (7), 3446, 2021 | 23 | 2021 |
| The role of the Hippo pathway in breast cancer carcinogenesis, prognosis, and treatment: a systematic review A Kyriazoglou, M Liontos, R Zakopoulou, M Kaparelou, A Tsiara, ... Breast Care 16 (1), 6-15, 2021 | 20 | 2021 |
| The impact of sodium glucose co‐transporter 2 inhibitors on non‐alcoholic fatty liver disease L Chrysavgis, AM Papatheodoridi, A Chatzigeorgiou, E Cholongitas Journal of Gastroenterology and Hepatology 36 (4), 893-909, 2021 | 17 | 2021 |
| Hepatocellular carcinoma: the virus or the liver? A Papatheodoridi, G Papatheodoridis Liver International 43, 22-30, 2023 | 12 | 2023 |
| Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA Mutations A Varkaris, F Fece de la Cruz, EE Martin, BL Norden, N Chevalier, ... Cancer Discovery 14 (2), 227-239, 2024 | 11 | 2024 |
| Supportive medication in cancer during pregnancy F Zagouri, N Dedes, A Papatheodoridi, M Liontos, MA Dimopoulos BMC Pregnancy and Childbirth 20, 1-9, 2020 | 11 | 2020 |
| SARS-CoV-2 neutralizing antibodies kinetics postvaccination in cancer patients under treatment with immune checkpoint inhibition E Terpos, M Liontos, O Fiste, F Zagouri, A Briasoulis, AD Sklirou, ... Cancers 14 (11), 2796, 2022 | 10 | 2022 |
| Significance of circulating cell-free DNA species in non-alcoholic fatty liver disease L Chrysavgis, A Papatheodoridi, E Cholongitas, M Koutsilieris, ... International Journal of Molecular Sciences 22 (16), 8849, 2021 | 9 | 2021 |
| Metaplastic carcinoma of the breast: case series of a single institute and review of the literature A Papatheodoridi, E Papamattheou, S Marinopoulos, ... Medical Sciences 11 (2), 35, 2023 | 7 | 2023 |
| Germline and somatic variants in ovarian carcinoma: A next-generation sequencing (NGS) analysis A Andrikopoulou, E Zografos, K Apostolidou, A Kyriazoglou, ... Frontiers in Oncology 12, 1030786, 2022 | 7 | 2022 |
| Management of the elderly patients with high-grade serous ovarian cancer in the real-world setting M Liontos, A Papatheodoridi, A Andrikopoulou, N Thomakos, ... Current Oncology 28 (2), 1143-1152, 2021 | 7 | 2021 |
| Circulating cell‐free DNA species affect the risk of hepatocellular carcinoma in treated chronic hepatitis B patients A Papatheodoridi, A Chatzigeorgiou, L Chrysavgis, P Lembessis, A Loglio, ... Journal of Viral Hepatitis 28 (3), 464-474, 2021 | 6 | 2021 |
| Risk for venous thromboembolic events in patients with advanced urinary tract cancer treated with first-line chemotherapy A Bamias, K Tzannis, I Dimitriadis, G Tsironis, AM Papatheorodidi, ... Clinical Genitourinary Cancer 18 (4), e457-e472, 2020 | 6 | 2020 |
| Multi-gene mutation profiling by targeted next-generation sequencing in premenopausal breast cancer E Zografos, A Andrikopoulou, AM Papatheodoridi, M Kaparelou, G Bletsa, ... Genes 13 (8), 1362, 2022 | 4 | 2022 |
| Prolonged impact of anti-cancer therapy on endothelial function and arterial stiffness in breast cancer patients M Anastasiou, E Oikonomou, P Theofilis, GA Papamikroulis, M Gazouli, ... Vascular Pharmacology 152, 107195, 2023 | 3 | 2023 |
| Assessment of postvaccination neutralizing antibodies response against SARS-CoV-2 in cancer patients under treatment with targeted agents F Zagouri, A Papatheodoridi, M Liontos, A Briasoulis, AD Sklirou, ... Vaccines 10 (9), 1474, 2022 | 3 | 2022 |
| The significance of circulating cell-free DNA markers in chronic hepatitis B patients with hepatocellular carcinoma A Papatheodoridi, N Karakousis, P Lembessis, A Chatzigeorgiou, ... Pathogens 10 (11), 1524, 2021 | 2 | 2021 |
